How big is the Antibody Market | Revenue & Trends 2025

Q: What is the projected market size of the antibody industry by 2031?

The antibody market is anticipated to reach over USD 38.9 billion by 2031.

Q: What factors are contributing to the expansion of antibody market?

Key drivers include increased biologics adoption and technological advancements in antibody formulation and delivery.

Q: Are biosimilars affecting the original antibody market?

Yes, biosimilars are gaining ground as cost-effective alternatives, especially in mature markets, leading to price competition and broader access.

Q: What regions are expected to lead the antibody market growth?

Asia-Pacific is poised for the fastest growth due to increased biotech investments and growing healthcare infrastructure.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA5114

Publication Date: Jul 2025

How Big Is the Antibody Market?

According to 6Wresearch internal database and industry insights, the antibody market was valued at USD 23.8 billion in 2024 and is anticipated to exceed the valuation of USD 38.9 billion by 2031, growing at a CAGR of 8.7% over the forecast period.

This growth is fueled by growing demand for targeted therapies, rising prevalence of chronic illnesses, and global investment into immunotherapy and biosimilar development. Also, the further momentum of the market is stimulated by advancements in monoclonal antibody production technologies and the integration of AI in antibody discovery workflows.

Growth Factors of the Antibody Market

Increase in the global incidence of autoimmune diseases and cancer creating need for antibody-based therapeutics.
Advancements in recombinant DNA and antibody engineering.
Supportive regulatory landscape and accelerated assessments for biologics and monoclonal antibodies.
Continued increases in R&D spend by biotechnology and pharmaceutical firms.
Increased emphasis on biosimilars following expiration of blockbuster biologics.
Advances in diagnostic and therapeutic application areas including oncology, infectious diseases, and neurology.

Antibody Market Trends

The antibody landscape is undergoing a technological transformation, with companies integrating AI for faster antibody screening and selection. Bispecific and antibody-drug conjugates (ADCs) are gaining traction, offering targeted action with reduced side effects. A strong trend is the adoption of humanized and fully human antibodies to reduce immunogenicity.

Emerging Developments in Antibody Market

Several emerging developments are occurring in the Antibody Market. Next-generation antibody formats including nanobodies, multispecific antibodies and antibody fragments have potential to transform therapeutic possibilities. Therapy customization formats are gaining strong momentum particularly in our oncology therapeutic areas, in addition subcutaneous delivery options may also enable greater patient compliance. With continued adoption of AI and machine learning in early-stage discovery, antibody therapeutics are moving toward fast development cycles, precise targeting, and scaled cost efficiency.